We suggest that the response curve, RDSP, can be considered as a biomarker (characteristic signature) of a particular cancer signaling pathways (e.g., MAPK, PI3K/AKT, Wnt, and others (53) in specific cancer cell lines. The gene discussed is PIK3CA; the disease is cancer.